CODX
Co-Diagnostics second quarter 2026 revenue of $0.17M beat estimates as FDA submission was filed
Co-Diagnostics reported second quarter 2026 revenue of $0.17 million, outperforming the $0.13 million consensus estimate. The company’s net loss narrowed to...
